Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas. - Welling DB; Collier KA; Burns SS; Oblinger JL; Shu E; Miles-Markley BA; Hofmeister CC; Makary MS; Slone HW; Blakeley JO; Mansouri SA; Neff BA; et al. (Laryngoscope investigative otolaryngology, 2021)